Integrated DNA Technologies (IDT) has obtained a licence from Applied Biosystems to sell dual-labelled probes for use in the 5' Nuclease process, a technique for real-time PCR.
The licence awarded to IDT is the first in a new Probe Manufacturing License programme from Applied Biosystems.
The licence includes rights under several probe composition and methods patents to make and sell custom dual-labelled probes and primers mixed in assay-ready formats.
The licence to the composition and methods patents permit customers to purchase probes from IDT that are licensed for use in the 5' Nuclease Assay.
Researchers currently buy probes and primers in separate tubes, often from separate vendors that disclaim any licensed right of the customer to use the probes in the 5' Nuclease Assay.
The licence to the '375 patent will make it possible for IDT to offer design services for probes and primers for use in the assay and supply researchers with the resulting probes and primers in a more convenient, ready-to-use format.
The Probe Manufacturing License programme grants licensees rights to make and sell custom oligonucleotides and oligonucleotide sets for use in the 5' Nuclease process under patents owned by Applied Biosystems and Roche.
The licence allows sales to researchers and to existing commercial licensees under Applied Biosystems' Kit and Commercial Services licensing programmes.
